Innovation Pharmaceuticals Inc (IPIX)

[Darwinian]

I kind of wonder if the reason the market is slow to react is because B is a completely new MOA. There may be a lot of eyes on us waiting for more concrete/definitive results. It's always a bigger risk to invest in something, more or less, untried/unproven. B isn't just a rehash of an existing drug as many antibiotics are, that may frighten some.

Settle down y'all.